NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

No. LP and some large holders got a special deal. In return for three year extension, they restricted themselves from exercising warrants for 6 months to November 1. Whether that has any value is contingent mainly upon two things:
1. TLD is released during that period and the results are at least reasonably good and,
2. The market reacts favorably to the announcement.

Other investors needed to make a capital contribution to extend warrants, a value which is not contingent.

Essentially the restriction is risk less as they have three full years to realize value. LP as CEO has the potential to delay TLD until after the restriction period is over. There may be a ho-hum reaction by the market as the manipulators have thus far had a very successful run in driving the SP down. Are they powerful enough to keep doing it even in the face of good results? There is uncertainty here. Better value for LP and cohorts is more likely with RA approvals which are surely to issue beyond the restrictive period.

My view?

If LP's value given is contingent, so should the extension of her warrants be. For example, no TLD/tepid market reaction, the warrants so extended should be expired at the end of the restrictive period. Fair is fair.